Saturday 17 October 2026
Export WAY’s income statement to Excel — free account
Waystar Holding Corp.
WAY Healthcare Health Information Services
Waystar Holding Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.1 billion, up 16.5% from fiscal 2024. In the quarter to June 2026, revenue grew 18.1%, EPS grew 10.5%, free cash flow fell 52.4% and total debt rose 18.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years.
27.36
0.88
−3.12%
Follow WAY
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
P/E ratio |
51.17 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
6 | 6 | — | — |
Altman Z-Score |
2.16 | 2.49 | — | — |
P/S ratio |
5.30 | 5.83 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
2.47 | 2.51 | 1.06 | 1.04 |
P/FCF ratio |
20.58 | 38.61 | 71.73 | 71.73 |
P/Operating CF |
87.45 | 84.95 | 234.73 | 234.73 |
Beneish M-Score |
(2.41) | (2.47) | (2.40) | — |
P/B ratio |
1.50 | 1.79 | 1.23 | 1.23 |
Price to Tangible BV |
0.00 | 0.00 | 1.23 | 1.23 |
EV/Sales |
6.55 | 6.93 | 0.00 | 0.00 |
EV/EBITDA |
18.34 | 20.81 | 0.00 | 0.00 |
EV/Operating CF |
23.24 | 38.53 | 75.62 | 75.62 |
EV/FCF |
25.42 | 45.90 | 133.94 | 133.94 |
Quick Ratio |
1.31 | 2.42 | 1.44 | 1.80 |
Current Ratio |
1.41 | 2.55 | 1.80 | 2.13 |
Net Debt/EBITDA |
3.49 | 3.31 | 6.64 | 7.66 |
Debt/Assets |
25.46% | 27.17% | 48.66% | 47.69% |
Debt/Equity |
0.38 | 0.40 | 1.09 | 1.06 |
Asset Turnover |
0.21 | 0.21 | 0.17 | 0.00 |
Operating CF/Net income |
2.76 | (8.88) | (1.00) | (1.99) |
Capex/Depreciation |
(0.18) | (0.14) | (0.12) | (0.09) |
Interest Coverage |
3.22 | 0.85 | 0.69 | 0.58 |
| 3.22% | (0.75%) | (2.47%) | 0.00% | |
| 2.16% | (0.42%) | (1.11%) | 0.00% | |
ROIC |
2.97% | 1.88% | 2.10% | 1.31% |
Return on Tangible Assets |
78.94% | (7.03%) | (32.12%) | (30.00%) |
Average Days of Receivables |
60.92 | 57.28 | 61.32 | 57.70 |
Research and Development Expense of Revenue |
4.97% | 5.17% | 4.47% | 4.65% |
Selling, General and Administrative Expense of Revenue |
27.89% | 28.48% | 23.69% | 26.18% |
Intangible Assets out of Total Assets |
0.92 | 0.89 | 0.92 | 0.92 |
Share Based Compensation of Revenue |
3.83% | 5.77% | 1.12% | 1.14% |
Graham Net Nets |
(0.27) | (0.20) | (0.92) | (0.92) |
Graham Number |
17.72 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
1.95% | (0.55%) | (2.59%) | (2.59%) |
Free Cash Flow Yield |
4.86% | 2.59% | 1.39% | 1.39% |
Revenue per Share |
6.18 | 6.29 | 6.50 | 5.79 |
Operating CF per Share |
1.74 | 1.13 | 0.42 | 0.84 |
Capex per Share |
(0.15) | (0.18) | (0.18) | (0.14) |
Free Cash Flow per Share |
1.59 | 0.95 | 0.25 | 0.70 |
Cash per Share |
0.57 | 1.36 | 0.37 | 0.60 |
Shareholders Equity per Share |
21.80 | 20.54 | 16.85 | 17.31 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
21.80 | 20.54 | 16.85 | 17.31 |
Free Cash Flow |
283.19 | 142.50 | 29.94 | 85.20 |
Working Capital |
90.35 | 225.41 | 98.56 | 115.69 |
Capital Expenditures |
(26.48) | (27.27) | (21.52) | (17.43) |
Net Current Asset Value |
(1,597.86) | (1,126.18) | (2,310.99) | (2,370.26) |
EV/EBIT |
28.87 | 52.87 | 0.00 | 0.00 |
Capex to Sales |
0.02 | 0.03 | 0.03 | 0.02 |
Price to Operating Income |
23.37 | 44.47 | 0.00 | 0.00 |
| Other line items | ||||
Depreciation/Fixed assets |
2.77 | 4.08 | 3.05 | 3.46 |
Cash ROIC |
5.19% | 3.15% | 0.69% | 1.93% |
Accounts Receivable Turnover |
6.63 | 6.72 | 6.47 | 0.00 |
Accounts Payable Turnover |
7.08 | 6.80 | 6.79 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
53.41 | 54.76 | 66.47 | 47.72 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
165.77 | 140.49 | 122.17 | — |
Average Payables |
49.16 | 46.42 | 36.79 | — |
Average Assets |
5,181.05 | 4,579.99 | 4,638.68 | — |
Average Common Equity |
3,479.31 | 2,564.86 | 2,078.08 | — |
Columns are period end dates